moderna-biontechs-post-covid-futures-oncology-hit-manufacturing-realities Manufacturing Related Topics 
XTalks
SEPTEMBER 14, 2020
“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. Moderna’s COVID-19 Vaccine. Johnson & Johnson’s COVID-19 Vaccine.
pharmaphorum
JANUARY 6, 2022
However, what makes 2022 different in this respect is Big Tech’s positioning to ride the trends of healthcare digitisation, remote delivery and data utilisation, which have been started or accelerated by the COVID-19 pandemic. Medicine budget constraint, structural fund largesse. RNA Therapeutics come to the fore.
Expert insights. Personalized for you.
92 
Let's personalize your content